These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 21376584)

  • 1. 2,3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure-activity relationship study.
    Chen Q; Bryant VC; Lopez H; Kelly DL; Luo X; Natarajan A
    Bioorg Med Chem Lett; 2011 Apr; 21(7):1929-32. PubMed ID: 21376584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of [1,2,4]triazolo[4,3-a]quinoxaline-1,3,4-oxadiazole derivatives as potent antiproliferative agents via a hybrid pharmacophore approach.
    Kaneko D; Ninomiya M; Yoshikawa R; Ono Y; Sonawane AD; Tanaka K; Nishina A; Koketsu M
    Bioorg Chem; 2020 Nov; 104():104293. PubMed ID: 33010622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antitumor activities of a series of novel quinoxalinhydrazides.
    Grande F; Aiello F; Grazia OD; Brizzi A; Garofalo A; Neamati N
    Bioorg Med Chem; 2007 Jan; 15(1):288-94. PubMed ID: 17085054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis.
    Alsaif NA; Dahab MA; Alanazi MM; Obaidullah AJ; Al-Mehizia AA; Alanazi MM; Aldawas S; Mahdy HA; Elkady H
    Bioorg Chem; 2021 May; 110():104807. PubMed ID: 33721808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro antitumor activity of substituted quinazoline and quinoxaline derivatives: search for anticancer agent.
    Noolvi MN; Patel HM; Bhardwaj V; Chauhan A
    Eur J Med Chem; 2011 Jun; 46(6):2327-46. PubMed ID: 21458891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aza-isoindolo and isoindolo-azaquinoxaline derivatives with antiproliferative activity.
    Parrino B; Carbone A; Spanò V; Montalbano A; Giallombardo D; Barraja P; Attanzio A; Tesoriere L; Sissi C; Palumbo M; Cirrincione G; Diana P
    Eur J Med Chem; 2015 Apr; 94():367-77. PubMed ID: 25778992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of derivatives of 6(7)-amino-3-phenylquinoxaline-2-carbonitrile 1,4-dioxides: novel, hypoxia-selective HIF-1α inhibitors with strong antiestrogenic potency.
    Buravchenko GI; Scherbakov AM; Dezhenkova LG; Bykov EE; Solovieva SE; Korlukov AA; Sorokin DV; Monzote Fidalgo L; Shchekotikhin AE
    Bioorg Chem; 2020 Nov; 104():104324. PubMed ID: 33142432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinoxalin-2(1H)-one derivatives as inhibitors against hepatitis C virus.
    Liu R; Huang Z; Murray MG; Guo X; Liu G
    J Med Chem; 2011 Aug; 54(16):5747-68. PubMed ID: 21761853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinoxaline chemistry. Part 16. 4-substituted anilino and 4-substituted phenoxymethyl pyrrolo[1,2-a]quinoxalines and N-[4-(pyrrolo[1,2-a]quinoxalin-4-yl)amino and hydroxymethyl]benzoyl glutamates. Synthesis and evaluation of in vitro biological activity.
    Alleca S; Corona P; Loriga M; Paglietti G; Loddo R; Mascia V; Busonera B; La Colla P
    Farmaco; 2003 Sep; 58(9):639-50. PubMed ID: 13679156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naphthyl quinoxaline thymidine conjugate is a potent anticancer agent post UVA activation and elicits marked inhibition of tumor growth through vaccination.
    Yuan Y; Wang Z; Yang R; Qian T; Zhou Q
    Eur J Med Chem; 2019 Jun; 171():255-264. PubMed ID: 30925340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of 3-(benzazol-2-yl)quinoxaline derivatives as potent anticancer compounds: Privileged structure-based design, synthesis, and bioactive evaluation in vitro and in vivo.
    Liu QQ; Lu K; Zhu HM; Kong SL; Yuan JM; Zhang GH; Chen NY; Gu CX; Pan CX; Mo DL; Su GF
    Eur J Med Chem; 2019 Mar; 165():293-308. PubMed ID: 30685528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of 3-aryl-quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives as hypoxic selective anti-tumor agents.
    Hu Y; Xia Q; Shangguan S; Liu X; Hu Y; Sheng R
    Molecules; 2012 Aug; 17(8):9683-96. PubMed ID: 22890172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulphonamido-quinoxalines: search for anticancer agent.
    Ingle R; Marathe R; Magar D; Patel HM; Surana SJ
    Eur J Med Chem; 2013 Jul; 65():168-86. PubMed ID: 23708011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer properties of N-alkyl-2, 4-diphenylimidazo [1, 2-a] quinoxalin-1-amine derivatives; kinase inhibitors.
    Rezaei Z; Mahdi Didehvar M; Mahdavi M; Azizian H; Hamedifar H; Mohammed EHM; Ostad S; Amini M
    Bioorg Chem; 2019 Sep; 90():103055. PubMed ID: 31220669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of in vitro antiproliferative activity of new ethyl 3-(arylethynyl)quinoxaline-2-carboxylate and pyrido[4,3-b]quinoxalin-1(2H)-one derivatives.
    Hajri M; Esteve MA; Khoumeri O; Abderrahim R; Terme T; Montana M; Vanelle P
    Eur J Med Chem; 2016 Nov; 124():959-966. PubMed ID: 27770736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological evaluation of N-substituted 3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carboxylic acid derivatives as tubulin polymerization inhibitors.
    Qi J; Dong H; Huang J; Zhang S; Niu L; Zhang Y; Wang J
    Eur J Med Chem; 2018 Jan; 143():8-20. PubMed ID: 29172084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of novel anti-tuberculosis agents with pyrrolo[1,2-a]quinoxaline-based scaffold.
    Wang T; Tang Y; Yang Y; An Q; Sang Z; Yang T; Liu P; Zhang T; Deng Y; Luo Y
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2084-2090. PubMed ID: 29748048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anticancer activity as inhibitors of c-Met kinase.
    Abbas HA; Al-Marhabi AR; Eissa SI; Ammar YA
    Bioorg Med Chem; 2015 Oct; 23(20):6560-72. PubMed ID: 26420384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1,2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines.
    Desplat V; Vincenzi M; Lucas R; Moreau S; Savrimoutou S; Pinaud N; Lesbordes J; Peyrilles E; Marchivie M; Routier S; Sonnet P; Rossi F; Ronga L; Guillon J
    Eur J Med Chem; 2016 May; 113():214-27. PubMed ID: 26945110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and antiproliferative evaluation of new quinoxalines as potential DNA intercalators and topoisomerase II inhibitors.
    Eissa IH; Metwaly AM; Belal A; Mehany ABM; Ayyad RR; El-Adl K; Mahdy HA; Taghour MS; El-Gamal KMA; El-Sawah ME; Elmetwally SA; Elhendawy MA; Radwan MM; ElSohly MA
    Arch Pharm (Weinheim); 2019 Nov; 352(11):e1900123. PubMed ID: 31463953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.